1-9 of 9
Chiara Ciochetto
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Myc and Bcl2 Overexpression and Traslocation Assessed By Immunohystochemistry (IHC) and FISH: Retrospective Analysis in a Series of De Novo DLBCL Homogeneously Treated with Rituximab-CHOP

Chiara Ciochetto, Maria Stella Scalzo, Barbara Botto, Alessia Castellino, Annalisa Chiappella, MD, Mattia Novo, Maura Nicolosi, Elisa Santambrogio, Federica Cavallo, MD, Paola Ghione, Andrea Evangelista, MSc, Giovannino Ciccone, MD PhD, Roberto Chiarle, MD, Domenico Novero, MD, Umberto Vitolo, MD
Journal: Blood
Blood (2016) 128 (22): 5305.
https://doi.org/10.1182/blood.V128.22.5305.5305
Published: 2016
Journal Articles

De-Novo Diffuse Large B Cell Lymphoma (DLBCL) Treated with Rituximab (R)-CHOP: Definition and Validation of a Prognostic Score Model Based on MYC, BCL2 and BCL6 Expression By Immunohistochemistry (IHC)

Barbara Botto, Alessia Castellino, Annalisa Chiappella, Mattia Novo, Luigi Zattera, Federica Cavallo, Paola Ghione, Andrea Evangelista, Chiara Ciochetto, Giovannino Ciccone, Maria Stella Scalzo, Roberto Chiarle, Domenico Novero, Umberto Vitolo
Journal: Blood
Blood (2015) 126 (23): 2650.
https://doi.org/10.1182/blood.V126.23.2650.2650
Published: 2015
Journal Articles

The Prognostic Value of MYC, BCL2 and BCL6 Overexpression Evaluated By Immunohistochemistry (IHC) in De-Novo Diffuse Large B Cell Lymphoma (DLBCL) Treated with Rituximab-CHOP

Barbara Botto, Domenico Novero, Annalisa Chiappella, Mattia Novo, Alessia Castellino, Chiara Ciochetto, Giovanni Cametti, Andrea Evangelista, Roberto Freilone, Paola Ghione, Marco Ladetto, Paola Riccomagno, Federico Vittone, Giovannino Ciccone, Umberto Vitolo
Journal: Blood
Blood (2014) 124 (21): 2964.
https://doi.org/10.1182/blood.V124.21.2964.2964
Published: 2014
Journal Articles

Relapsed Or Refractory Aggressive Non Hodgkin B-Cell Lymphomas Treated With Lenalidomide With/Without Rituximab Or Steroids: A Single Center Restrospective Study

Alessia Castellino, Annalisa Chiappella, Paola Ghione, Manuela Ceccarelli, Giulia Benevolo, MD, Barbara Botto, Daniele Caracciolo, Chiara Ciochetto, Maura Nicolosi, Lorella Orsucci, Clara Pecoraro, Patrizia Pregno, Paola Riccomagno, Manuela Zanni, Marco Ladetto, Umberto Vitolo, MD
Journal: Blood
Blood (2013) 122 (21): 5119.
https://doi.org/10.1182/blood.V122.21.5119.5119
Published: 2013
Journal Articles

Brief Chemoimmunotherapy Rituximab, Bendamustine, Mitoxantrone (R-BM) Followed by Rituximab Consolidation in Elderly Patients with Untreated Advanced Stage Follicular Lymphoma (FL): Preliminary Results of a Prospective Phase II Study by Fondazione Italiana Linfomi (FIL).

Carola Boccomini, Marco Ladetto, MD, Luigi Rigacci, Luca Arcaini, Manuela Ceccarelli, Chiara Lobetti-Bodoni, Stefano Volpetti, Lorella Orsucci, Annalisa Chiarenza, Roberto Freilone, Paolo Corradini, Silvia Bolis, Silvia Franceschetti, Paola Riccomagno, Chiara Rusconi, Alfonso Zaccaria, Caterina Stelitano, Anna Marina Liberati, Chiara Ciochetto, Luca Baldini, MD, Monica Balzarotti, MD, Alessandra Tucci, Umberto Vitolo
Journal: Blood
Blood (2012) 120 (21): 2720.
https://doi.org/10.1182/blood.V120.21.2720.2720
Published: 2012
Journal Articles

Rituximab Plus Dose Intense Rapid-Cycling Chemotherapy with Intrathecal CNS Prophylaxis in Patients with Burkitt Lymphoma (BL) and Intermediate Unclassifiable Diffuse Large B-Cell Lymphoma/BL: Single Institution Experience

Chiara Frairia, Chiara Ciochetto, Ernesta Audisio, Giulia Benevolo, MD, Barbara Botto, MD, Annalisa Chiappella, Maura Nicolosi, Lorella Orsucci, Clara Pecoraro, Patrizia Pregno, MD, Filippo Marmont, Umberto Vitolo, MD
Journal: Blood
Blood (2011) 118 (21): 1631.
https://doi.org/10.1182/blood.V118.21.1631.1631
Published: 2011
Journal Articles

Radioimmunotherapy (RIT) with 90 yttrium Zevalin Followed by BEAM Conditioning Regimen (Z-BEAM) and Autologous Stem Cell Transplantation (ASCT) for the Treatment of High Risk Relapsed/Resistant Non Hodgkin's Lymphoma (NHL)

Barbara Botto, MD, Chiara Ciochetto, Marilena Bellò€, Roberto Passera, Giulia Benevolo, MD, Carola Boccomini, MD, Annalisa Chiappella, Roberto Freilone, Francesca Giunta, Maura Nicolosi, Erika Orlandi, Lorella Orsucci, Clara Pecoraro, Patrizia Pregno, MD, Anna Tonso, Gianni Bisi, Umberto Vitolo, MD
Journal: Blood
Blood (2011) 118 (21): 3107.
https://doi.org/10.1182/blood.V118.21.3107.3107
Published: 2011
Journal Articles

The Outcome of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab-CHOP (R-CHOP) Is Not Predicted by 18-FDG-Positron Emission Tomography/Computerized Tomography (PET) Performed at Intermediate In-Course Evaluation, but Only by PET Assessed at the End of Therapy.

Umberto Vitolo, Annalisa Chiappella, Marilena Bellò€, Roberto Passera, Barbara Botto, Giancarlo Castellano, Chiara Ciochetto, Simone Ferrero, Chiara Frairia, Silvia Franceschetti, Francesca Giunta, Marco Ladetto, Massimo Menga, Maura Nicolosi, Giorgio Priolo, Benedetta Puccini, Luigi Rigacci, Flavia Salvi, Luca Vaggelli, Patrizia Pregno, Gianni Bisi
Journal: Blood
Blood (2010) 116 (21): 2819.
https://doi.org/10.1182/blood.V116.21.2819.2819
Published: 2010
Journal Articles

Retrospective Analysis of 206 Mantle Cell Lymphoma Patients at Diagnosis: Mantle Cell International Prognostic Index (MIPI) Is a Good Predictor of Death Event In Patients Treated Either with Rituximab-Chemotherapy or Rituximab-High-Dose-Chemotherapy

Annalisa Chiappella, Benedetta Puccini, Simone Ferrero, Luca Arcaini, Ileana Baldi, Giulia Benevolo, Carola Boccomini, Barbara Botto, Chiara Ciochetto, Sergio Cortelazzo, Alberto Fabbri, Chiara Frairia, Cristina Gabutti, Marco Ladetto, Michael Mian, Domenico Novero, Lorella Orsucci, Patrizia Pregno, Giorgio Priolo, Luigi Rigacci, Marianna Rossi, Chiara Rusconi, Umberto Vitolo
Journal: Blood
Blood (2010) 116 (21): 1784.
https://doi.org/10.1182/blood.V116.21.1784.1784
Published: 2010